Abstract
Background: This meta-analysis of randomized controlled trials (RCTs) investigated the usefulness of Janus kinase (JAK) inhibitors among hospitalized patients with COVID-19.
Methods: PubMed, Web of Science, the Cochrane Library, and Ovid MEDLINE were searched for RCTs published before 7 September 2021. Only RCTs that compared the clinical efficacy and safety of JAK inhibitors with other alternative treatments or placebos in the treatment of hospitalized patients with COVID-19 were included.
Results: Overall, patients receiving JAK inhibitors exhibited a lower 28-day mortality rate than the control group (risk ratio [RR], 0.60; 95% CI, 0.47-0.77; I 2 = 0%). Compared with the control group, the study group also had a lower 14-day mortality rate (RR, 0.60; 95% CI, 0.42-0.85; I 2 = 0%), a higher rate of clinical improvement (RR, 1.05; 95% CI, 1.02-1.09; I 2 = 0%), and less need of mechanical ventilation or extracorporeal membrane oxygenation (RR, 0.64; 95% CI, 0.50-0.84; I 2 = 0%). Finally, JAK inhibitor use was associated with a similar risk of adverse events and infections as that observed in the control group.
Conclusions: JAK inhibitors can help reduce mortality and improve clinical outcomes among hospitalized patients with COVID-19. Additionally, JAK inhibitors can be used safely in this clinical entity.
Keywords: COVID-19; Janus kinase inhibitor; SARS-CoV-2; mortality.
【저자키워드】 COVID-19, SARS-CoV-2, mortality., Janus kinase inhibitor, 【초록키워드】 Randomized controlled trial, Treatment, Meta-analysis, Randomized controlled trials, Mortality, mechanical ventilation, Infection, 28-day mortality, risk, hospitalized patients, RCT, clinical outcomes, adverse events, extracorporeal membrane oxygenation, adverse event, Patient, Clinical improvement, jak inhibitors, Placebo, mortality rate, inhibitor, Jak, JAK inhibitor, RCTs, Kinase inhibitor, Clinical efficacy, Janus kinase, risk ratio, Web of Science, control group, study group, 95% CI, janus, help, Cochrane Library, OVID, placebos, reduce mortality, investigated, receiving, exhibited, can be used, less, searched, hospitalized patient, improve clinical outcome, the study group, with COVID-19, 【제목키워드】 Randomized controlled trial, Meta-analysis, hospitalized patient,